跳轉至內容
Merck

Adverse drug reactions induced by valproic acid.

Clinical biochemistry (2013-06-25)
Radu M Nanau, Manuela G Neuman
摘要

Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic profiles, as well as a relatively favorable safety profile. However, adverse drug reactions have been reported in relation with valproic acid use, either as monotherapy or polytherapy with other antiepileptic drugs or antipsychotic drugs. This systematic review discusses valproic acid adverse drug reactions, in terms of hepatotoxicity, mitochondrial toxicity, hyperammonemic encephalopathy, hypersensitivity syndrome reactions, neurological toxicity, metabolic and endocrine adverse events, and teratogenicity.

材料
產品編號
品牌
產品描述

Supelco
丙戊酸, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
丙戊酸标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
2-丙基戊酸
USP
丙戊酸, United States Pharmacopeia (USP) Reference Standard
丙戊酸, European Pharmacopoeia (EP) Reference Standard